| Product Code: ETC9964048 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United States (US) Deep Vein Thrombosis Market Overview |
3.1 United States (US) Country Macro Economic Indicators |
3.2 United States (US) Deep Vein Thrombosis Market Revenues & Volume, 2021 & 2031F |
3.3 United States (US) Deep Vein Thrombosis Market - Industry Life Cycle |
3.4 United States (US) Deep Vein Thrombosis Market - Porter's Five Forces |
3.5 United States (US) Deep Vein Thrombosis Market Revenues & Volume Share, By Drugs, 2021 & 2031F |
4 United States (US) Deep Vein Thrombosis Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of deep vein thrombosis (DVT) cases in the United States |
4.2.2 Growing awareness about the risks associated with DVT and the need for early diagnosis and treatment |
4.2.3 Technological advancements in diagnostic tools and treatment options for DVT |
4.3 Market Restraints |
4.3.1 High cost of DVT treatment and management, which may limit access to care for some patients |
4.3.2 Potential side effects and complications associated with DVT medications and procedures |
4.3.3 Stringent regulatory requirements for DVT treatment options, which may slow down the introduction of new therapies |
5 United States (US) Deep Vein Thrombosis Market Trends |
6 United States (US) Deep Vein Thrombosis Market, By Types |
6.1 United States (US) Deep Vein Thrombosis Market, By Drugs |
6.1.1 Overview and Analysis |
6.1.2 United States (US) Deep Vein Thrombosis Market Revenues & Volume, By Drugs, 2021- 2031F |
6.1.3 United States (US) Deep Vein Thrombosis Market Revenues & Volume, By Arixtra (Fondaparinux sodium), 2021- 2031F |
6.1.4 United States (US) Deep Vein Thrombosis Market Revenues & Volume, By Fragmin (Dalteparin sodium), 2021- 2031F |
6.1.5 United States (US) Deep Vein Thrombosis Market Revenues & Volume, By Eliquis (Apixaban), 2021- 2031F |
6.1.6 United States (US) Deep Vein Thrombosis Market Revenues & Volume, By Savaysa (Edoxaban), 2021- 2031F |
6.1.7 United States (US) Deep Vein Thrombosis Market Revenues & Volume, By Xarelto (Rivaroxaban), 2021- 2031F |
6.1.8 United States (US) Deep Vein Thrombosis Market Revenues & Volume, By Abelacimab, 2021- 2031F |
7 United States (US) Deep Vein Thrombosis Market Import-Export Trade Statistics |
7.1 United States (US) Deep Vein Thrombosis Market Export to Major Countries |
7.2 United States (US) Deep Vein Thrombosis Market Imports from Major Countries |
8 United States (US) Deep Vein Thrombosis Market Key Performance Indicators |
8.1 Number of screenings conducted for DVT in the United States |
8.2 Adoption rate of minimally invasive DVT treatment procedures |
8.3 Patient satisfaction and outcomes post-DVT treatment |
8.4 Average time to diagnosis and treatment initiation for DVT patients |
8.5 Rate of recurrence of DVT cases |
9 United States (US) Deep Vein Thrombosis Market - Opportunity Assessment |
9.1 United States (US) Deep Vein Thrombosis Market Opportunity Assessment, By Drugs, 2021 & 2031F |
10 United States (US) Deep Vein Thrombosis Market - Competitive Landscape |
10.1 United States (US) Deep Vein Thrombosis Market Revenue Share, By Companies, 2024 |
10.2 United States (US) Deep Vein Thrombosis Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here